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Review of the Current Status of Intra-
Arterial Thrombolysis for Treating Acute
Cerebral Infarction: a Retrospective
Analysis of the Data from Multiple
Centers in Korea
Objective: The purpose of the study was to review the current status of intra-
arterial (IA) thrombolysis in Korea by conducting a retrospective analysis of the
data from multiple domestic centers. 
Materials and Methods: The radiologists at each participating institution were
asked to fill out case report forms on all patients who had undergone IA recanal-
ization due to acute anterior circulation ischemia. These forms included clinical,
imaging and procedure-related information. A central reader analyzed the CT/MR
and angiographic results. The rates of successful recanalization, hemorrhagic
transformation and functional outcome were obtained. The univariate analyses
were performed together with the multivariate analysis. 
Results: We analyzed the data from 163 patients, and they had been treated at
seven institutes. The initial imaging modalities were CT for 46 patients (28%), MR
for 63 (39%), and both for 54 (33%). Various mechanical treatment methods were
applied together in 50% of the patients. Radiologically significant hemorrhage
was noted in 20/155 patients (13%). We found various factors that influenced the
recanalization rate and the occurrence of significant hemorrhagic transforma-
tions. The favorable outcome rate, reported as modified Rankin Scale  2, was
40%, and the mortality rate was 11%. The factors that predicted a poor functional
outcome were old age (p = 0.01), initially severe neurological symptoms (p <
0.0001), MR findings of a wide distribution of lesions (p = 0.001), involvement of
the basal ganglia (p = 0.01), performance of procedures after working hours (p =
0.01), failure of recanalization (p = 0.003), contrast extravasation after the proce-
dure (p = 0.007) and significant hemorrhagic transformation (p = 0.002). The sub-
sequent multivariate analysis failed to show any statistically significant variable.
Conclusion: There was a trend toward increased dependency on MR imaging
during the initial evaluation and increased usage of combined
pharmacologic/mechanical thrombolysis. The imaging and clinical outcome
results of this study were comparable to those of the previous major thrombolytic
trials.
ith the first successful use of local intra-arterial (IA) thrombolysis for
vertebrobasilar disease (1), many studies have shown that IA application
of thrombolytics can successfully treat hyperacute ischemic strokes (2
8). However, in Korea, this procedure has yielded variable results (9 11). A combina-
tion of microcatheter techniques with their improved performance has increased the
effectiveness and safety of IA thrombolysis. In addition to the local infusion of
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Wthrombolytics, balloon angioplasty catheters, various
metallic stents and other mechanical measures have also
been used to increase the recanalization rate (12 14).
In the single successful randomized controlled trial of IA
thrombolysis that has been conducted to date, the
PROACT-II Trial (7), thrombolytic pro-urokinase was
infused over two hours without manipulation of the clot.
Yet the techniques used for IA thrombolysis differ from
one center to another, according to the endovascular
technique, and the outcomes of this procedure, as
measured by the recanalization rate and the functional
outcome, have not been consistent (15). This lack of
standardization, along with the inconsistent outcomes, has
prompted us to investigate the current IA thrombolysis
techniques and their radiological and clinical results in
Korea. Therefore, in conjunction with the Stroke Study
Group of the Korean Society of Neuroradiology and Head
& Neck Radiology (KSNHNR), we retrospectively
analyzed the current status of IA thrombolytic therapy for
the treatment of acute cerebral ischemic lesions. We
determined what modalities are used for the radiological
evaluation and the findings, the treatment patterns and the
short-term clinical results, including the rate of
hemorrhagic transformation, the mortality rate and the
clinical outcome, and we determined some of factors that
are prognostic for a poor outcome. 
MATERIALS AND METHODS
The study was designed as a multicenter, retrospective
collection of cases with using a case reporting form. Only
patients who underwent an IA recanalization procedure
due to acute anterior circulation ischemia in the internal
carotid artery (ICA) and the middle cerebral artery (MCA),
and this was performed within the past five years, were
included in this review.
The case reporting form was provided to each enrolled
institute. This form included the basic clinical information,
the initial imaging results, the angiography and procedure-
related information, the follow-up imaging results and the
clinical outcome of each patient together with the actual
imaging data. We requested that the clinical and
procedure-related parts of the form be filled out by the
radiologist at each center.
The basic clinical information included age, gender,
National Institute of Health Stroke Scale (NIHSS) score at
the time of presentation and the presence of underlying
diabetes, hypertension and/or heart disease. Selection of
the initial imaging modality, the time from symptom onset
to the time of imaging, the time from symptom onset to the
initiation of angiography (the first angiographic run), and
the time of day of the procedure (i.e., during or after
working hours) were analyzed.
The pre- and post-procedure CT/MR images and
angiographic findings were evaluated by the board-
certified radiologist who had more than five years of
experience with IA thrombolysis. The CT results were
analyzed for the presence of early CT signs, involvement
of basal ganglia and the presence of hyperdense MCA
signs. The MR findings were analyzed to determine the
extent of the lesion on the diffusion-weighted images
(DWI), involvement of the basal ganglia, the presence of
perfusion/diffusion mismatch and presence of microbleeds.
The angiographic results were analyzed for the anatomic
location of the culprit steno-occlusive lesions and the initial
and post-procedure Thrombolysis in Myocardial Infarction
(TIMI) grades. We regarded a post-procedure TIMI grade
of II or III as indicative of successful recanalization. 
The immediate post-procedure CT was reviewed for the
presence of hemorrhages and parenchymal hyperdensity
that was observed due to the contrast media used during
the thrombolytic procedure. The follow-up CT or MR
findings were analyzed for occurrence of hemorrhagic
transformation, which was evaluated by the European
Cooperative Acute Stroke Study (ECASS) classification
method. We calculated the rates of occurrence of any
hemorrhage and any radiologically significant hemorrhage,
with the latter regarded as hemorrhage with a mass effect,
such as parenchymal hematoma type 2 or some cases of
hemorrhagic infarction type 2. These rates were surrogate
indicators of symptomatic hemorrhages (16, 17).
The clinical outcome analysis was performed using the
modified Rankin Scale (mRS), which was recorded at
various time points after the procedure (at 1 12 months,
except for the patients who died in the interim). If the
clinical outcome data were not available, the case was
dropped from the clinical outcome analysis. We calculated
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Table 1. Demographic Characteristics at the Baseline
n/N* (percentage)
Total number of patients 163
Men 110/163 (68%)
Mean age (yrs) 63 12
Mean initial NIHSS score 14 50
Diabetes 24/147 (16%)
Hypertension 78/150 (52%)
Etiologic classification**
Large artery stenosis 57/163 (35%)
Cardioembolism 54/163 (33%)
Other causes or unclassified 51/163 (32%)
Note. n = number, * N = the number of patients with available data.
**According to the Trial of Org 10172 in Acute Stroke Treatment (TOAST).the percentage of patients with each mRS score, as well as
the mortality rate, which was defined as the rate of
procedure-related deaths within one month. 
Univariate logistic regression methods were used to
analyze the factors that had an influence on successful
recanalization, significant hemorrhagic transformation and
poor functional outcome results. The proportion of patients
with a mRS of more than 3 was used for the latter.
Variables with p values less than 0.05 on the univariate
analyses were chosen as the variables for the multivariate
logistic regression analysis. In both analyses, p values less
than 0.05 were considered statistically significant.
RESULTS
Patient Demographics
The basic demographic characteristic of the 163 patients
from seven domestic institutes are summarized in Table 1.
The mean time interval from the symptom onset to the
initial CT scanning was 139 145 minutes and the mean
time interval from the symptom onset to the first angiogra-
phy was 280 178 minutes (Table 2). Out of the 149
patients for whom we were able to obtain the time of day
of their angiography, 92 (62%) had the procedures
performed during normal working hours (09:00 18:00).
Initial Imaging Results
The initial imaging modalities were CT in 46 patients
(28%), MR in 63 (39%), and both CT and MR in 54
(33%). We were able to review the CT images of 69 of the
100 (69%) patients who initially underwent CT. The basic
initial CT and MR findings are summarized in Tables 3 and
4, respectively. 
Angiography and Procedure
The site of arterial stenosis (TIMI grade 1, n = 18) or
occlusion (TIMI grade 0, n = 145) was the ICA, including
the carotid ‘T’ occlusion, in 62 patients (38%), the MCA,
including M2 occlusion, in 99 (61%) and the anterior
cerebral artery in two patients (1.2%) (Table 5). Before the
initiation of IA thrombolysis, 73 patients (45%) were
administered intravenous tissue plasminogen activator (t-
PA, 0.6 or 0.9 mg/kg). Urokinase at a median dosage of
400,000 IU (range 40,000 1,000,000 IU) was the IA
fibrinolytic agent in 139 patients (85%), t-PA at a median
dosage of 10 mg (range 5 20 mg) was used in 11 patients
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Table 2. Time from Symptom Onset to the Initial Imaging
and Treatment (the First Angiography)
Time to Imaging Minutes
From symptom onset to CT (n = 71) 139 145
From symptom onset to MR (n = 61) 206 207
From CT to MR (n = 47) 60 52
Time to Treatment
From symptom onset (n = 144) 280 178
From CT (n = 71) 128 680
From MR (n = 61) 107 530
Table 3. Initial CT Findings in 69 Patients
N (percentage)
Early CT sign
None 31 (45%)
Less than 1/3 of the MCA territory 31 (45%)
Over 1/3 of the MCA territory 7 (10%)
Low density involving the basal ganglia
No 52 (75%)
Less than 1/2 8 (12%)
Over 1/2 9 (13%)
Positive hyperdense MCA sign
No 49 (71%)
Yes 20 (29%)
Note. N = number, MCA = middle cerebral artery.
Table 4. Initial MR Findings in 98 Patients
N/Total (percentage)
Extent of the DWI lesion in the involved vascular territory
Less than 1/3  54/98 (55%)
Less than 1/2 19/98 (19%)
Over 1/2 25/98 (26%)
Location of the DWI lesion
Predominantly cortical 13/98 (13%)
Predominantly subcortical 30/98 (31%)
Both cortical and subcortical 55/98 (56%)
Lesion involvement of basal ganglia
None 32/98 (32%)
Less than 1/2 29/98 (30%)
Over 1/2 37/98 (38%)
Diffusion/perfusion mismatch in 56 patients who underwent
PWI
No 07/56 (13%)
Yes 49/56 (87%)
GRE dark clot sign
GRE (+) 35/98 (36%)
No 24/35 (69%)
Yes 11/35 (31%)
Microbleed on GRE
GRE (+) 42/98 (43%)
None 29/42 (69%)
Less than 5 07/42 (17%)
More than 6 06/42 (14%)
Note. N = number, DWI = diffusion-weighted image, PWI = perfusion-
weighted image, GRE = gradient echo image.(7%), and the procedure was performed without IA
fibrinolytics in 13 patients (8%). In the latter case, mechan-
ical methods were primarily applied, except for one
patient, who received an IA infusion of abciximab. Various
mechanical methods were applied, along with local
infusion of fibrinolytics, in 82 patients (50%), including
those patients who were treated with primary mechanical
thrombolysis. The methods employed included mechanical
disruption of the clot using a micro-guidewire (n = 49,
60%), stenting of the steno-occlusive lesion using various
kinds of metallic stents (n = 17, 21%), balloon catheter
angioplasty or clot disruption (n = 12, 14%) and aspiration
of the clot using a large-bore guiding catheter (n = 4, 5%).
A combination of these methods was used in patients for
whom the primary mechanical method was ineffective in
recanalization. 
Postprocedure angiography was available for 152
patients. The final TIMI grades were zero in 21 patients
(14%), one in 23 (15%), two in 31 (20%) and three in 77
(51%). The successful recanalization (TIMI grade 2 or 3)
rate was 71%. 
Postprocedure Imaging Results
Immediate postprocedure CT was available for 117
patients. Various patterns of parenchymal high densities
were observed in 54 patients (47%), and 24 (21%) of
them showed obvious hematoma formation and/or high
density with a mass effect.
Hemorrhagic transformation of the lesion was evaluated
in 155 patients whose follow-up CT and/or MR images
were available for the review, and 55 (35%) of these
patients showed variable amounts of hemorrhage. The
hemorrhage pattern was hemorrhagic infarction (HI) type
1 in 15 patients (27%), HI type 2 in six (11%), parenchy-
mal hematoma (PH) type 1 in 17 (31%) and PH type 2 in
17 (31%). Radiologically significant hemorrhage was noted
in 20 of these 155 patients (13%).
Clinical Outcome
The clinical follow-up data were available for 158
patients. The follow-up period varied from one to 12
months, except for those patients who died in the interim.
We noted mRS scores of zero in 17 patients (11%), one in
27 (17%), two in 19 (12%), three in 20 (13%), four in 33
(21%) and five in 24 (15%); these findings were compara-
ble with those of other major thrombolysis trials (Fig. 1).
Out of the 158 patients, 18 died, yielding a mortality rate
of 11%.
Results of the Univariate and Multivariate Analyses
Among the various factors considered, an initial NIHSS
score of less than 15 was the only factor that positively
influenced successful recanalization (p = 0.001). Table 6
shows the univariate analysis of the factors that influenced
significant hemorrhage after the procedure, and Table 7
shows the factors that influenced the poor functional
outcome. Subsequent multivariate analyses failed to show
any statistically significant variables both for significant
hemorrhage and for a poor functional outcome. 
DISCUSSION
The results of our analysis provide an overview on the
current practice status of IA thrombolysis in Korea.
Although more than 30 centers in Korea actively perform
neurointerventional procedures (see the 2005 member list
of the Korean Society of Interventional Neuroradiology),
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Table 5. Anatomic Sites of Stenosis or Occlusion on the
Initial Angiography
Anatomic Site N (percentage)
ICA 62 (38%)
Proximal ICA 13 (8%)
Proximal ICA and tandem 
MCA occlusion 7 (4%)
Distal ICA 6 (4%)
Carotid T lesion 36 (22%)
MCA 99 (61%)
Proximal MCA trunk 35 (22%)
Mid MCA trunk 16 (10%)
Distal MCA trunk 35 (22%)
M2 13 (8%)
ACA 2 (1%)
Note. N = number, ICA = internal carotid artery, MCA = middle cerebral 
artery, ACA = anterior cerebral artery.
Fig. 1. Functional outcome represented as modified Rankin
Scale and comparison of the current results with those of the
control and treated groups of the major thrombolysis trials.only seven of these centers participated in this study. It is
likely that many of the other centers have been reluctant
to perform IA thrombolysis, primarily due to a shortage of
trained personnel. In Western countries also, IA thrombol-
ysis is performed less frequently than the IV method due to
a shortage of interventional specialists (15).
We found that from the symptom onset, the mean time
before the imaging was 2.3 hours, and the mean time
before the treatment was 4.7 hours; these results are
comparable with those reported in the PROACT II Trial
(7). The mean delay between the CT and MR imaging was
about 60 min, which was one of the in-hospital delay
factors for IA thrombolysis (18). 
About 40% of these procedures were performed before
or after normal working hours, and the functional outcome
results of these patients were generally poorer than those
of the patients who were treated during normal working
hours. One of the primary reasons for the poorer outcome
in the former group of patients may be the in-hospital
delay. A well-organized stroke team and an on-call system
may improve the results for these patients.
One notable finding of our survey was the preference for
MR as the initial imaging modality. MR was the sole initial
imaging modality in 39% of patients, and it was combined
with the CT imaging in 33%. Although MR has the
potential disadvantage of time delay, it has shown an
advantage for the initial evaluation of acute ischemic
stroke (19 22). However, a delay in the initiation of the
optimal treatment due to logistic limitations of MR imaging
cannot be justified. Many centers use multi-detector CT
imaging to overcome the inevitable logistic limitation of
MR imaging (21, 23).
It was notable that about 10% of the cases in the study
were in violation of the ‘one-third rule’, which is one of the
most important exclusion criteria of the European
thrombolysis trial (24) and the PROACT II trial (7). Out of
all the patients evaluated by the MR imaging, 26% showed
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Table 6. Univariate Relationships of the Significant
Hemorrhage after Thrombolysis
Variable Odds Ratio P value
Demographic
Age (> 65 yrs) 0.70 0.46
Sex (male) 0.32 0.08
Diabetes 0.96 0.95
Hypertension 3.03 0.044
Cardioembolism 1.38 0.51
Initial NIHSS score  15 3.75 0.046
CT findings
Positive early CT sign 1.80 0.38
Violation of one-third rule 4.42 0.08
Basal ganglia involvement 4.08 0.03
Hyperdense MCA sign (+) 1.21 0.73
MR findings
DWI lesion over 1/3 of MCA territory 0.86 0.81
DWI lesion over 1/2 of MCA territory 1.55 0.51
Basal ganglia involvement 3.93 0.042
Presence of diffusion-perfusion mismatch 0.84 0.88
Visible dark clot on T2*-weighted images 8.63 0.08
Procedure and post-procedure imaging findings
After working hours 2.82 0.038
Within 3 hours after symptom onset 1.64 0.46
Within 6 hours after symptom onset 0.39 0.22
Combined IV thrombolysis 0.79 0.62
Combined mechanical thrombolysis 0.93 0.88
Failed recanalization 0.86 0.77
Any contrast staining on post-CT 15.8 < 0.0001
Contrast extravasation on post-CT 14.9 < 0.0001
Note. DWI = diffusion-weighted image, MCA = middle cerebral artery.
Table 7. Univariate Relationships with a Poor Functional
Outcome (mRS > 3)
Variable Odds Ratio P value
Demographic
Age (> 65 yrs) 02.27 0.010
Sex (male) 00.87 0.680
Diabetes 01.52 0.350
Hypertension 01.12 0.730
Cardioembolism 00.88 0.700
Initial NIHSS score  15 04.88 < 0.0001
CT findings
Positive early CT sign 01.57 0.370
Violation of the one-third rule 05.80 0.120
Basal ganglia involvement 01.26 0.680
Hyperdense MCA sign (+) 01.21 0.730
MR findings
DWI lesion over 1/3 of MCA territory 02.35 0.040
DWI lesion over 1/2 of MCA territory 06.14 0.001
Basal ganglia involvement 03.22 0.010
Presence of diffusion-perfusion mismatch 0.003
Visible dark clot on T2*-weighted images 02.10 0.330
Procedure and post-procedure imaging findings
After working hours 02.41 0.010
Within 3 hours after symptom onset 00.98 0.970
Within 6 hours after symptom onset 00.93 0.870
Combined IV thrombolysis 01.08 0.800
Combined mechanical thrombolysis 00.96 0.890
Failed recanalization 00.31 0.003
Any contrast staining on post-CT 02.33 0.030
Contrast extravasation on post-CT 04.00 0.007
Significant hemorrhage 26.70 0.002
Note. DWI = diffusion-weighted image, MCA = middle cerebral artery.DWI lesions covering more than half of the involved
vascular territory. This was probably due to a lack of
certain inclusion or exclusion criteria for MR imaging in
respect to the patient selection for IA thrombolysis.
Although we limited our study to patients with anterior
circulation infarction and so increasing the homogeneity of
the study group, we found a wide variation in the
occlusion site, from the proximal ICA to the proximal
portion of the MCA.
Our observed recanalization rate, 71%, was slightly
higher than that reported in the PROACT II trial (7), which
may have been due, at least in part, to the liberal use of
mechanical methods (14). We were disappointed to find
that only one factor, the lower initial NIHSS score, had a
significant effect on the successful recanalization rate. In
contrast to reports on the combined or sequential
thrombolytic treatments (25 27), we found that the use of
IV thrombolytics prior to the IA procedure did not affect
the recanalization rate. However, in many of these
patients, however, the initial IV administration of
thrombolytics was ineffective. About half of the patients
received a combination of IA and mechanical thromboly-
sis, although the use of mechanical methods failed to
improve the recanalization rate (p = 0.083). 
One of the major concerns after the IA thrombolytic
treatment is hemorrhagic transformation of the affected
lesion (28, 29). We found that the rate of any amount
hemorrhagic transformation was 35%, and the rate of the
significant hemorrhagic transformation was 13%. The
univariate analysis showed that several factors that had
influence on significant hemorrhagic transformation,
including the presence of hypertension, severe initial
neurological symptoms, involvement of the basal ganglia
on CT/MR and the performance of procedures after
normal working hours. In addition, the risk of significant
hemorrhage was increased by the presence of any contrast
density on the CT obtained immediately after the
thrombolysis procedure. Violation of the one-third rule on
the initial CT tended to increase the occurrence of signifi-
cant hemorrhage (p = 0.08), whereas extensive involve-
ment of the affected vascular territory on the DWI (p =
0.51) and the combined use of IV thrombolytics and
mechanical methods had no effect.
Although direct comparison is not possible because of
the differences in the patient groups, the functional
outcome in our series of patients was similar to that of
other major thrombolysis trials (7, 30). Among the factors
that were found to influence the poor functional outcome
were the old age, severe initial neurological symptoms,
more extensive initial DWI lesions and involvement of
basal ganglia on MR, failed recanalization, any contrast
staining on CT immediately after the procedure and the
presence of significant hemorrhagic transformation. Other
studies have found that these same factors were predictive
of poor prognosis (8, 31, 32).
The primary limitations of this analysis were its
retrospective design and the collection of data from several
centers, all of which had different clinical and imaging
indications for the procedure and different clinical settings.
In addition, the data we collected were not representative
of practice throughout Korea because only a few active
centers contributed to the study. Due to our inability to
collect some data from the participating centers, we were
unable to perform appropriate multivariate analyses. This
could be one of the possible reasons for our failure to
determine any significant variables that affected the results
of significant hemorrhagic transformation and poor
functional outcomes. Furthermore, our analysis of the
imaging data was limited due to the between-center differ-
ences in the imaging protocols, including the use of
contrast enhancement, MR pulse sequences and the
angiographic filming techniques. Nevertheless, the results
presented here may be representative of the nation-wide
data on current IA thrombolytic treatment, and they could
serve as a basis for clinical practice guidelines, as well as
for designing a prospective study on the basis of this
protocol.
In conclusion, our multicenter, retrospective analysis of
IA thrombolysis showed an increased dependency on MR
imaging during the initial patient evaluation and increased
application of combined pharmacologic/mechanical
thrombolysis in Korea. Both our imaging and clinical
outcome results were comparable with those of the other
major thrombolytic trials. Our results could be used as the
basis for clinical practice and for future prospective studies. 
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